SCHEMBL24592385

SCHEMBL24592385

Cc1ccc2[nH]nc(N)c2c1C(C)(C)Cn1nc(O)c2c(C(C)C)c(C)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924098 0.88 LCK (0.32) —
SCHEMBL20970415 0.78 KDR (0.31) —
SCHEMBL24592387 0.72 — —
SCHEMBL19115759 0.72 PDPK1 (0.42) —
SCHEMBL24854354 0.70 PDPK1 (0.38) —
SCHEMBL24592344 0.69 — —
SCHEMBL22349087 0.67 MAPK1 (0.36) —
SCHEMBL19104285 0.67 PDPK1 (0.42) —
SCHEMBL25724145 0.66 — —
SCHEMBL21982541 0.63 MAPK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377441-B2 Covalent inhibitors of KRAS ARAXES PHARMA LLC (US) 2022-07-05 — — US disclosed
Send feedback